Evidence map›Paper›PMID 25460572›Full record

ArticleBone2015

The parathyroid hormone-regulated transcriptome in osteocytes: parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function.

Hillary C St John, Mark B Meyer, Nancy A Benkusky, Alex H Carlson, Mathew Prideaux, Lynda F Bonewald, J Wesley Pike

Open access · greenAbstract read
In one paragraph

Article in Bone, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Vitamins DFrontiers in immunology · 2022
    Trial
  2. Article
  3. Article
  4. Genomic mechanisms controlling renal vitamin D metabolism.The Journal of steroid biochemistry and molecular biology · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. RNA-seq in Skeletal Biology.Current osteoporosis reports · 2019
    Review
  10. Review
  11. Article
  12. Regulation of Bone Remodeling by Parathyroid Hormone.Cold Spring Harbor perspectives in medicine · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. PTH Signaling and Epigenetic Control of Bone Remodeling.Current molecular biology reports · 2016
    Article
  19. Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hillary C St JohnDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Mark B MeyerDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Nancy A BenkuskyDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Alex H CarlsonDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA.
Mathew PrideauxDepartment of Oral Biology, School of Dentistry, University of Missouri, Kansas City, MO 64110, USA.
Lynda F BonewaldDepartment of Oral Biology, School of Dentistry, University of Missouri, Kansas City, MO 64110, USA.
J Wesley PikeDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: pike@biochem.wisc.edu.
University of Wisconsin–Madison · USUniversity of Missouri–Kansas City · US

Funding

Dynamic Mechanisms of Vitamin D-Induced Gene ExpressionR01DK072281 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI PIKE, J WESLEY · 2005 to 2012
$2.6M
Integrative genomics to define osteocyte differentiation, regulation and functionR01AR064424 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI PIKE, J WESLEY · 2014 to 2018
$1.7M
NIAMS NIH HHS AR-064424NIAMS NIH HHS R01 AR064424NIDDK NIH HHS DK-072281NIDDK NIH HHS R01 DK072281
6 · The paper itself

Abstract

Although localized to the mineralized matrix of bone, osteocytes are able to respond to systemic factors such as the calciotropic hormones 1,25(OH)2D3 and PTH. In the present studies, we examined the transcriptomic response to PTH in an osteocyte cell model and found that this hormone regulated an extensive panel of genes. Surprisingly, PTH uniquely modulated two cohorts of genes, one that was expressed and associated with the osteoblast to osteocyte transition and the other a cohort that was expressed only in the mature osteocyte. Interestingly, PTH's effects were largely to oppose the expression of differentiation-related genes in the former cohort, while potentiating the expression of osteocyte-specific genes in the latter cohort. A comparison of the transcriptional effects of PTH with those obtained previously with 1,25(OH)2D3 revealed a subset of genes that was strongly overlapping. While 1,25(OH)2D3 potentiated the expression of osteocyte-specific genes similar to that seen with PTH, the overlap between the two hormones was more limited. Additional experiments identified the PKA-activated phospho-CREB (pCREB) cistrome, revealing that while many of the differentiation-related PTH regulated genes were apparent targets of a PKA-mediated signaling pathway, a reduction in pCREB binding at sites associated with osteocyte-specific PTH targets appeared to involve alternative PTH activation pathways. That pCREB binding activities positioned near important hormone-regulated gene cohorts were localized to control regions of genes was reinforced by the presence of epigenetic enhancer signatures exemplified by unique modifications at histones H3 and H4. These studies suggest that both PTH and 1,25(OH)2D3 may play important and perhaps cooperative roles in limiting osteocyte differentiation from its precursors while simultaneously exerting distinct roles in regulating mature osteocyte function. Our results provide new insight into transcription factor-associated mechanisms through which PTH and 1,25(OH)2D3 regulate a plethora of genes important to the osteoblast/osteocyte lineage.

Indexed as

Gene Expression RegulationTranscriptome3T3 CellsAnimalsBone and BonesCalcitriolCell DifferentiationChromatin ImmunoprecipitationCyclic AMP Response Element-Binding ProteinEpigenesis, GeneticGene Expression ProfilingHumansMiceOsteoblastsOsteocytesParathyroid HormoneCalcitriolCREB1 protein, humanCyclic AMP Response Element-Binding ProteinParathyroid HormoneChIP-seqOsteocytePTHRNA-seqTranscriptional regulation

Identifiers

PMID25460572
PMCPMC4285334
OpenAlexW1986500372

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.